{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"Cartesian Therapeutics, Inc."},"Symbol":{"label":"Symbol","value":"RNAC"},"Address":{"label":"Address","value":"65 GROVE STREET, WATERTOWN, Massachusetts, 02472, United States"},"Phone":{"label":"Phone","value":"+1 617 923-1400"},"Industry":{"label":"Industry","value":"Biotechnology: Pharmaceutical Preparations"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"Selecta Biosciences Inc is a clinical-stage biopharmaceutical company. The company uses its ImmTOR immune tolerance platform, which is designed to give rise to antigen-specific immunity, mitigating unwanted immune responses. Its product pipeline includes MMA-101, SEL-212 for Chronic Severe Gout, SEL-313 for Ornithine Transcarbamylase Deficiency (OTC), and others."},"CompanyUrl":{"label":"Company Url","value":"https://www.cartesiantherapeutics.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Andy Stewart","title":"Senior Director-Research"},{"name":"Carsten Brunn","title":"President & Chief Executive Officer"},{"name":"Chris Jewell","title":"Chief Scientific Officer"},{"name":"Metin Kurtoglu","title":"Chief Technology Officer"},{"name":"Milos Miljkovic","title":"Chief Medical Officer"},{"name":"Zhang Yi","title":"Senior Director-Technology"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}